Rüssmann B - Search Results

1

Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Kröger N, Krüger W, Wacker-Backhaus G, Hegewisch-Becker S, Stockschläder M, Fuchs N, Rüssmann B, Renges H, Dürken M, Bielack S, de Wit M, Schuch G, Bartels H, Braumann D, Kuse R, Kabisch H, Erttmann R, Zander AR. Kröger N, et al. Among authors: russmann b. Bone Marrow Transplant. 1998 Dec;22(11):1029-33. doi: 10.1038/sj.bmt.1701498. Bone Marrow Transplant. 1998. PMID: 9877263

2

Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B.

Krüger WH, Kröger N, Rüssmann B, Renges H, Kabisch H, Zander AR. Krüger WH, et al. Among authors: russmann b. Bone Marrow Transplant. 1998 Dec;22 Suppl 4:S10-3. Bone Marrow Transplant. 1998. PMID: 9916623 Clinical Trial.

3

Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.

Krüger W, Rüssmann B, Kröger N, Salomon C, Ekopf N, Elsner HA, Kaulfers PM, Mack D, Fuchs N, Dürken M, Kabisch H, Erttmann R, Zander AR. Krüger W, et al. Among authors: russmann b. Bone Marrow Transplant. 1999 Mar;23(6):589-97. doi: 10.1038/sj.bmt.1701614. Bone Marrow Transplant. 1999. PMID: 10217190

4

Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.

Zander AR, Zabelina T, Kröger N, Renges H, Krüger W, Löliger C, Dürken M, Stockschläder M, de Wit M, Wacker-Backhaus G, Bielack S, Jaburg N, Rüssmann B, Erttmann R, Kabisch H. Zander AR, et al. Among authors: russmann b. Bone Marrow Transplant. 1999 May;23(9):889-93. doi: 10.1038/sj.bmt.1701745. Bone Marrow Transplant. 1999. PMID: 10338043 Clinical Trial.

5

Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B.

Krüger WH, Rüssmann B, de Wit M, Kröger N, Renges H, Sobottka I, Zander AR. Krüger WH, et al. Among authors: russmann b. Acta Haematol. 2005;113(2):104-8. doi: 10.1159/000083447. Acta Haematol. 2005. PMID: 15802888

6

Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.

Krüger W, Stockschläder M, Rüssmann B, Berger C, Hoffknecht M, Sobottka I, Kohlschütter B, Kroschke G, Kröger N, Horstmann M, et al. Krüger W, et al. Among authors: russmann b. Br J Haematol. 1995 Nov;91(3):684-90. doi: 10.1111/j.1365-2141.1995.tb05369.x. Br J Haematol. 1995. PMID: 8555076

7

Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values.

Krüger W, Sobottka I, Stockschläder M, Mross K, Hoffknecht M, Rüssmann B, Horstmann M, Betker R, Zander A. Krüger W, et al. Among authors: russmann b. Scand J Infect Dis. 1996;28(3):313-6. doi: 10.3109/00365549609027181. Scand J Infect Dis. 1996. PMID: 8863370

8

[Experiences with ambulatory cardiologic phase II rehabilitation].

Schönstedt S, Beckmann S, Disselhoff W, Rüssmann B. Schönstedt S, et al. Among authors: russmann b. Herz. 1999 Apr;24 Suppl 1:3-8. doi: 10.1007/BF03042126. Herz. 1999. PMID: 10372303 German.

9

[Sensibilization rate with haptenes in patients with neoplasms].

Remy W, Russmann B, Stüttgen G. Remy W, et al. Among authors: russmann b. Med Welt. 1974 Oct 25;25(43):1749-52. Med Welt. 1974. PMID: 4424177 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters